scispace - formally typeset
Open AccessJournal ArticleDOI

mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase

Papia Ghosh, +3 more
- 01 Feb 2008 - 
- Vol. 7, Iss: 3, pp 373-381
TLDR
It is demonstrated that mTORC1-mediated signaling events require the function of the 26S proteasome, and the data suggest that the CUL4-DDB1 ubiquitin ligase interacts with Raptor and regulates the mTORc1- mediated signaling pathway through ubiquit in-dependent proteolysis.
Abstract
The mammalian target-of-rapamycin (mTOR) signaling pathway serves as a major regulator of cell growth, cell size, and metabolism. In vivo, mTOR exists in two complexes, both of which contain the catalytic subunit mTOR, the invariable subunit mLST8, and a complex specific subunit Raptor or Rictor, forming either the rapamycin-sensitive mTORC1 or rapamycin-insensitive mTORC2, respectively. The exact functions of Raptor or Rictor in these complexes are still unclear. Here we demonstrate that mTORC1-mediated signaling events require the function of the 26S proteasome. Inhibition of the 26S proteasome by MG132 leads to the rapid inhibition of phosphorylation of the mTORC1 substrates S6 kinase and 4E-BP1. We have further discovered that the WD40 repeat proteins Raptor and mLST8 bind the CUL4-DDB1 ubiquitin E3 ligase. Loss of CUL4B or DDB1 specifically blocks the phosphorylation of S6 kinase at threonine 389 and 4E-BP1 at serine 65 and threonines 37 and 46, while loss of CUL4B enhances the phosphorylation of AKT...

read more

Citations
More filters
Journal ArticleDOI

mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.

TL;DR: This work describes an mTOR-dependent phosphorylation-driven pathway for DEPTOR destruction via SCF(βTrCP) and reveals a positive feedback loop involving mTOR and CKI-dependent turnover of its inhibitor, DEPTor, suggesting that misregulation of the DEptOR destruction pathway might contribute to aberrant activation of mTOR in disease.
Journal ArticleDOI

Comprehensive assessment of cancer missense mutation clustering in protein structures

TL;DR: A general method to detect cancer genes based on significant 3D clustering of mutations relative to the structure of the encoded protein products and the results indicate that systematic consideration of 3D structure can assist in the identification of cancer genes and in the understanding of the functional role of their mutations.
Journal ArticleDOI

A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery.

TL;DR: The structure reveals that HBx binds DDB1 through an α-helical motif, which is also found in the unrelated paramyxovirus SV5-V protein despite their sequence divergence, and reveals a common yet promiscuous structural element that is important for the assembly of cellular and virally hijacked CUL4–DDB1 E3 complexes.
Journal ArticleDOI

Regulation of Autophagy by Kinases

TL;DR: This review focuses on the regulation of autophagy by several kinases with particular emphasis on serine/threonine protein kinases such as mTOR, AMP-activated protein kinase, Akt, mitogen-activatedprotein kinase (ERK, p38 and JNK) and protein Kinase C that are often deregulated in cancer and are important therapeutic targets.
Journal ArticleDOI

REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase.

TL;DR: It is shown that REDD1 is subject to ubiquitin‐mediated degradation mediated by the CUL4A–DDB1–ROC1–β‐TRCP E3 ligase complex and through the activity of glycogen synthase kinase 3β, which is crucially required for the restoration of mTOR signalling as cells recover from hypoxic stress.
References
More filters
Journal ArticleDOI

TOR signaling in growth and metabolism.

TL;DR: The physiological consequences of mammalianTORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.
Journal ArticleDOI

mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery

TL;DR: It is reported that mTOR forms a stoichiometric complex with raptor, an evolutionarily conserved protein with at least two roles in the mTOR pathway that through its association with mTOR regulates cell size in response to nutrient levels.
Journal ArticleDOI

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

TL;DR: It is found that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C alpha (PKCalpha) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.
Journal ArticleDOI

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

TL;DR: The data suggest that feedback down-regulation of receptor tyrosine kinase signaling is a frequent event in tumor cells with constitutive mTOR activation, and reversal of this feedback loop by rapamycin may attenuate its therapeutic effects, whereas combination therapy that ablates mTOR function and prevents Akt activation may have improved antitumor activity.
Journal ArticleDOI

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

TL;DR: Two distinct TOR complexes constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.
Related Papers (5)